Journal ArticleOPEN ACCESS

Increased hydrolysis of oximino-β-lactams by CMY-107, a Tyr199Cys mutant form of CMY-2 produced by Escherichia coli

Antimicrobial Agents and Chemotherapy (2015) 59(12) 7894-7898
DOI: 10.1128/AAC.01793-15
7Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The cephalosporinase CMY-107, a Tyr199Cys mutant form of CMY-2 encoded by an IncI self-transferable plasmid carried by an Escherichia coli clinical strain, was characterized. The enzyme hydrolyzed oximino-cephalosporins and aztreonam more efficiently than CMY-2 did.

Cite

CITATION STYLE

APA

Kotsakis, S. D., Miriagou, V., Vetouli, E. E., Bozavoutoglou, E., Lebessi, E., Tzelepi, E., & Tzouvelekis, L. S. (2015). Increased hydrolysis of oximino-β-lactams by CMY-107, a Tyr199Cys mutant form of CMY-2 produced by Escherichia coli. Antimicrobial Agents and Chemotherapy, 59(12), 7894–7898. https://doi.org/10.1128/AAC.01793-15

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free